Gilead Sciences is a leading biopharmaceutical company that discovers and develops innovative therapeutics focusing on areas of unmet medical needs. The company’s mission is to improve the care of patients suffering from life-threatening diseases around the world.
Since its establishment in 1987 in Foster City, California, Gilead Sciences has adopted a differentiated business model, which is focused on the development of innovative medicines for the treatment of life threatening conditions, providing patients and doctors important clinical benefits. Gilead Sciences managed to become quickly a leading company in the field, employing today more than 4,000 people and generating annual revenues which reached $ 7,9 billion in 2010.
The company’s ability to develop best-in-class therapeutics and commercialize them, combined with its strategy to remain focused on life-threatening diseases, rendered it one of the biggest success stories in the broader industry. In fact, Business Week magazine ranked Gilead Sciences first in the 2009 list of the “Top 50 Best Performing Companies”.
Focusing on areas of significant medical needs, Gilead Sciences seeks to expand access to education and treatment in developing countries, by supporting special programs aimed at achieving this goal. Moreover, it reinvests a portion of its profits in the discovery of new therapeutics against life-threatening diseases, such as HIV/ AIDS, Chronic Hepatitis, and more recently severe cardiovascular and respiratory diseases.
The company entered the Greek market in 2001 with innovative medicines to treat HIV/ AIDS, Hepatitis B and invasive systemic fungal infections. Today, Gilead Sciences Hellas employs 36 people primarily focusing on providing scientific information and supporting the promotion of public health. Within this scope, the company provides significant support for initiatives and activities related to HIV and Hepatitis B prevention, as well as for the early diagnosis and treatment of patients.
Rizoudos 2 & Thrakis, GR-167 77 Elliniko – Greece
+30 210 8930100
+30 210 9618260
General Manager: S. Charalampidis